A new study provides a well-needed glimmer of hope for treating Alzheimer’s disease. Focusing on a genetic form of early-onset dementia called dominantly inherited Alzheimer’s disease, scientists have ...

This article originally appeared on Undark. For decades, scientists have been trying to develop therapeutics for people living with Alzheimer’s disease, a progressive neurodegenerative disease that is ...

Maddy has a degree in biochemistry from the University of York and specializes in reporting on health, medicine, and genetics. Maddy has a degree in biochemistry from the University of York and ...

Many promising Alzheimer's drug trials have failed in the past few months. The latest trial from drugmaker Merck stopped Tuesday after a committee found that the drug had "virtually no chance of ...

An illustration depicts cells in an Alzheimer’s-affected brain, with abnormal levels of beta amyloid protein clumping together to form plaques that collect between neurons and disrupt cell function. - ...

NEW YORK CITY (AP) - An experimental treatment appears to delay Alzheimer's symptoms in some people genetically destined to get the disease in their 40s or 50s, according to new findings from ongoing ...